Judgment

The Tribunal's judgment of the Tribunal in relation to an appeal against a decision of the Competition and Markets Authority (“CMA”) dated 3 February 2022 regarding the supply of Prochlorperazine tablets in the UK (Case 50511-2)("the Decision"). 

For the reasons set out in the judgment the Tribunal unanimously allowed the appeals and set aside the Decision